Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The metabolic landscape of RAS-driven cancers from biology to therapy
Suman Mukhopadhyay, Matthew G. Vander Heiden, Frank McCormick
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 271-283
Open Access | Times Cited: 197

Showing 26-50 of 197 citing articles:

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
Dino Bekric, Matthias Ocker, Christian Mayr, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1826-1826
Open Access | Times Cited: 41
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Yinping Sun, Yongjie Sha, Guanhong Cui, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114624-114624
Closed Access | Times Cited: 41
Autophagy, Oxidative Stress and Cancer Development
Elisabeth Taucher, Iurii Mykoliuk, Melanie Fediuk, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1637-1637
Open Access | Times Cited: 39
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer
Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, et al.
Cancer Research (2023) Vol. 83, Iss. 5, pp. 735-752
Open Access | Times Cited: 34
Mitochondrial DNA induces nucleus pulposus cell pyroptosis via the TLR9-NF-κB-NLRP3 axis
Lü Peng, Huayong Zheng, Hao Meng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1
Chao Peng, Xi Li, Feng Ao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer
Xiameng Gai, Yingluo Liu, Xiaojing Lan, et al.
Cancer Research (2024) Vol. 84, Iss. 12, pp. 1963-1977
Closed Access | Times Cited: 13
Targeting the Metabolic Paradigms in Cancer and Diabetes
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 211-211
Open Access | Times Cited: 12
Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma
Xiaodong Li, Fanguang Meng, Hankang Wang, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 10
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
Vincent Tambay, Valérie–Ann Raymond, Marc Bilodeau
Cancers (2021) Vol. 13, Iss. 17, pp. 4484-4484
Open Access | Times Cited: 46
Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK
R. Nassif, Elias Chalhoub, Pia Chedid, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 319-319
Open Access | Times Cited: 34
The role of KRAS splice variants in cancer biology
Cristina Nuevo‐Tapioles, Mark R. Philips
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 32
Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury
Eric S. Peeples, Thiago C. Genaro‐Mattos
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7420-7420
Open Access | Times Cited: 31
The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
Simon Manuel Tria, Matthew Burge, Vicki Whitehall
Cancers (2023) Vol. 15, Iss. 8, pp. 2375-2375
Open Access | Times Cited: 20
CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
Xiaoqian Zhang, Xiaocui Zheng, Ying Xiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
3D Spheroid Configurations Are Possible Indictors for Evaluating the Pathophysiology of Melanoma Cell Lines
Hiroshi Ohguro, Megumi Watanabe, Tatsuya Sato, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 759-759
Open Access | Times Cited: 16
DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas
Gamze Bildik, Joshua P. Gray, Weiqun Mao, et al.
Autophagy (2024) Vol. 20, Iss. 3, pp. 675-691
Closed Access | Times Cited: 7
Targeting autophagy drug discovery: Targets, indications and development trends
Mengjia Jiang, Wayne Wu, Zijie Xiong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116117-116117
Closed Access | Times Cited: 7
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention
Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1057-1057
Open Access | Times Cited: 7
Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
Fen Xiao, Zhibin Wang, Qiao Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Chitosan based nanocarriers as a promising tool in treatment and management of inflammatory diseases
Shuchi Goyal, Divya Thirumal, Jaya Rana, et al.
Carbohydrate Polymer Technologies and Applications (2024) Vol. 7, pp. 100442-100442
Open Access | Times Cited: 6
The RAS oncogene in brain tumors and the involvement of let-7 microRNA
Samantha Messina
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 6
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
Johannes F. Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2543-2543
Open Access | Times Cited: 26
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 394-408
Closed Access | Times Cited: 25

Scroll to top